Burgues et al evaluated the response of men with hypogonadotropic hypogonadism to subcutaneous injections of follicle stimulating hormone (FSH) and human chorionic gonadogrophin (HCG). This was compared to existing therapy requiring intramuscular injections of the gonadotropins. The authors are from multiple hospitals in Spain.